Advertisement

Topics

UK NICE invites Roche to submit Cancer Drugs Fund proposal for atezolizumab

19:00 EDT 2 Aug 2017 | Pharmaceutical Technology

The UK National Institute for Health and Care Excellence (NICE) has invited Swiss healthcare company, Roche, to submit a Cancer Drugs Fund (CDF) proposal for its urothelial cancer drug, atezolizumab.

Original Article: UK NICE invites Roche to submit Cancer Drugs Fund proposal for atezolizumab

NEXT ARTICLE

More From BioPortfolio on "UK NICE invites Roche to submit Cancer Drugs Fund proposal for atezolizumab"

Quick Search
Advertisement
 

Relevant Topics

Drug Approvals
In order to become availible to pateints, drugs need to undergo a number of phases of clinical trials to test their efficacy and safty and to then be authorised by the drug approval organistion in each respective country. This is the FDA in the USA and N...

Healthcare
Health care (or healthcare) is the diagnosis, treatment, and prevention of disease, illness, injury, and other physical and mental impairments in humans. Health care is delivered by practitioners in medicine, chiropractic, dentistry, nursing, pharmacy, a...

Biotechnology Business
Alliances Astrazeneca Bioethics Boehringer Clinical Research Organization Collaborations GSK Johnson & Johnson Lilly Merck Mergers and Acquisitions Nexium Novartis Pfizer Roche Sanofi ...